{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:00:51Z","timestamp":1794013251949,"version":"4.8.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cca.2026.121100","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:09:36Z","timestamp":1779466176000},"page":"121100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Advances in laboratory diagnostic studies of pheochromocytoma and paraganglioma"],"prefix":"10.1016","volume":"591","author":[{"given":"Chang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.121100_bb0005","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0010","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0015","doi-asserted-by":"crossref","first-page":"bvac105","DOI":"10.1210\/jendso\/bvac105","article-title":"Systematic review: incidence of pheochromocytoma and paraganglioma over 70 years","volume":"6","author":"Al Subhi","year":"2022","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.cca.2026.121100_bb0020","doi-asserted-by":"crossref","first-page":"e2251","DOI":"10.1210\/clinem\/dgaa965","article-title":"Incidence and clinical presentation of pheochromocytoma and sympathetic paraganglioma: a population-based study","volume":"106","author":"Ebbehoj","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0025","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumors - a population-based study in Olmsted County, Minnesota","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabet. Endocrinol."},{"key":"10.1016\/j.cca.2026.121100_bb0030","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.121100_bb0035","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","author":"van Nederveen","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cca.2026.121100_bb0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cca.2026.121100_bb0050","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jmedgenet-2015-103218","article-title":"Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients","volume":"52","author":"Curr\u00e1s-Freixes","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cca.2026.121100_bb0055","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jmoldx.2017.04.009","article-title":"A targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics","volume":"19","author":"Curr\u00e1s-Freixes","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.cca.2026.121100_bb0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cca.2026.121100_bb0065","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/endrev\/bnae005","article-title":"The immune landscape of pheochromocytoma and paraganglioma: current advances and perspectives","volume":"45","author":"Uher","year":"2024","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.121100_bb0070","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/cancers11040586","article-title":"Chromogranin A in the laboratory diagnosis of pheochromocytoma and paraganglioma","volume":"11","author":"B\u00edlek","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.cca.2026.121100_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2024.101935","article-title":"Metabolomics and proteomics in pheochromocytoma and paraganglioma: Translating biochemistry and biology to bedside","volume":"38","author":"Petrak","year":"2024","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0080","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2589-7500(23)00094-8","article-title":"Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort","volume":"5","author":"Pamporaki","year":"2023","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.cca.2026.121100_bb0085","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO\u2013EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cca.2026.121100_bb0090","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41574-024-01024-5","article-title":"International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents","volume":"20","author":"Casey","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cca.2026.121100_bb0095","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cca.2026.121100_bb0100","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jcp.10.2.138","article-title":"The estimation of catecholamines in urine by a chemical method","volume":"10","author":"Weil-Malherbe","year":"1957","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0110","series-title":"Measurements of Plasma Metanephrines by Immunoassay vs Liquid Chromatography with Tandem Mass Spectrometry for Diagnosis of Pheochromocytoma","author":"Weismann","year":"2026"},{"key":"10.1016\/j.cca.2026.121100_bb0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/clinchem\/39.1.97","article-title":"Determination of metanephrines in plasma by liquid chromatography with electrochemical detection","volume":"39","author":"Lenders","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121100_bb0120","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2026.121100_bb0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2265.2012.04340.x","article-title":"Rapid circulatory clearances and half-lives of plasma free metanephrines","volume":"77","author":"Eisenhofer","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2026.121100_bb0130","series-title":"Comparison of Diagnostic Accuracy of Urinary Free Metanephrines, Vanillyl Mandelic Acid, and Catecholamines and Plasma Catecholamines for Diagnosis of Pheochromocytoma","author":"Boyle","year":"2026"},{"key":"10.1016\/j.cca.2026.121100_bb0135","series-title":"Overnight\/First-Morning Urine Free Metanephrines and Methoxytyramine for Diagnosis of Pheochromocytoma and Paraganglioma: is This an Option?","author":"Peitzsch","year":"2026"},{"key":"10.1016\/j.cca.2026.121100_bb0140","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3803\/EnM.2020.925","article-title":"Urinary free metanephrines for diagnosis of pheochromocytoma and paraganglioma","volume":"36","author":"Ahn","year":"2021","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"10.1016\/j.cca.2026.121100_bb0145","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/clinchem\/hvab060","article-title":"Harmonization of LC-MS\/MS measurements of plasma free normetanephrine, metanephrine, and 3-methoxytyramine","volume":"67","author":"Peitzsch","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121100_bb0150","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.3390\/jcm9103108","article-title":"Measurements of plasma-free metanephrines by immunoassay versus urinary metanephrines and catecholamines by liquid chromatography with amperometric detection for the diagnosis of pheochromocytoma\/paraganglioma","volume":"9","author":"Raber","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cca.2026.121100_bb0155","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/clinchem\/hvab064","article-title":"Diagnostic accuracy of salivary metanephrines in pheochromocytomas and paragangliomas","volume":"67","author":"Eijkelenkamp","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121100_bb0160","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/jcem.83.6.4870","article-title":"Plasma metanephrines are markers of pheochromocytoma produced by Catechol-O-Methyltransferase within tumors","volume":"83","author":"Eisenhofer","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0165","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.121100_bb0170","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/diagnostics13182940","article-title":"A laboratory medicine perspective on the investigation of phaeochromocytoma and paraganglioma","volume":"13","author":"Boot","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.cca.2026.121100_bb0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/EJE-17-0077","article-title":"Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma","volume":"177","author":"Rao","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2026.121100_bb0180","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumor size, location and SDHB mutation status","volume":"48","author":"Eisenhofer","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cca.2026.121100_bb0185","doi-asserted-by":"crossref","first-page":"1021420","DOI":"10.3389\/fendo.2022.1021420","article-title":"Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology","volume":"13","author":"Constantinescu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cca.2026.121100_bb0190","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJM199906173402404","article-title":"Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel\u2013Lindau disease and multiple endocrine neoplasia type 2","volume":"340","author":"Eisenhofer","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.121100_bb0195","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jc.2002-021251","article-title":"A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines","volume":"88","author":"Sawka","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0200","first-page":"5210","article-title":"Plasma metanephrine and normetanephrine measured by LC-MS\/MS in the diagnosis of pheochromocytoma and paraganglioma","volume":"10","author":"Luo","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.cca.2026.121100_bb0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/cclm.2011.742","article-title":"Enzyme-linked immunoassay for plasma-free metanephrines in the biochemical diagnosis of phaeochromocytoma in adults is not ideal","volume":"50","author":"Mullins","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.121100_bb0210","series-title":"Seasonal Variation in Plasma Free Normetanephrine Concentrations: Implications for Biochemical Diagnosis of Pheochromocytoma","author":"Pamporaki","year":"2026"},{"key":"10.1016\/j.cca.2026.121100_bb0215","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-19-0176","article-title":"A high rate of modestly elevated plasma normetanephrine in a population referred for suspected PPGL when measured in a seated position","volume":"181","author":"Boyd","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2026.121100_bb0220","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0004563216646395","article-title":"Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted\/seated patients","volume":"54","author":"Casey","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.cca.2026.121100_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.0300-0664.2001.01446.x","article-title":"Study of diurnal fluctuations of plasma methoxyamines in healthy volunteers","volume":"56","author":"Hoizey","year":"2002","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.cca.2026.121100_bb0235","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(69)90637-0","article-title":"Plasma-catecholamines after cardiac infarction","volume":"294","author":"Mcdonald","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2026.121100_bb0240","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jcp.2006.036640","article-title":"Catecholamine and metanephrine excess in intracerebral haemorrhage: revisiting an obscure yet common \u201cpseudophaeochromocytoma,\u201d","volume":"60","author":"Leow","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0245","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1523-1755.2005.67123.x","article-title":"Plasma metanephrines in renal failure","volume":"67","author":"Eisenhofer","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2026.121100_bb0250","first-page":"21","article-title":"Pseudo-pheochromocytoma due to obstructive sleep apnea: a case report","volume":"2022","author":"Jazdarehee","year":"2022","journal-title":"Endocrinol. Diabetes Metab. Case Rep"},{"key":"10.1016\/j.cca.2026.121100_bb0255","first-page":"737","article-title":"Expert consensus on the diagnosis and treatment of pheochromocytoma and paraganglioma (2020 edition)","volume":"36","author":"Chinese Society of Endocrinology","year":"2020","journal-title":"Chin. J. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergen.2012.01.009","article-title":"Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background","volume":"205","author":"Fishbein","year":"2012","journal-title":"Cancer Genet."},{"key":"10.1016\/j.cca.2026.121100_bb0265","series-title":"Genetic Bases of Pheochromocytoma and Paraganglioma","author":"Casc\u00f3n","year":"2023"},{"key":"10.1016\/j.cca.2026.121100_bb0270","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/cancers14030594","article-title":"New insights on the genetics of pheochromocytoma and paraganglioma and its clinical implications","volume":"14","author":"Jhawar","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121100_bb0275","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jmedgenet-2019-106214","article-title":"Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma\u2013paraganglioma","volume":"57","author":"Bayley","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cca.2026.121100_bb0280","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.121100_bb0285","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1210\/js.2018-00120","article-title":"Pathogenicity and penetrance of germline SDHA variants in pheochromocytoma and paraganglioma (PPGL)","volume":"2","author":"Maniam","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.cca.2026.121100_bb0290","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","article-title":"Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention","volume":"3","author":"Bausch","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.cca.2026.121100_bb0295","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.3390\/cancers14225508","article-title":"Depletion of fumarate hydratase, an essential TCA cycle enzyme, drives proliferation in a two-step model","volume":"14","author":"Solaimuthu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121100_bb0300","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12020-018-1617-1","article-title":"Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations","volume":"61","author":"Zhang","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2026.121100_bb0305","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s12094-021-02622-9","article-title":"Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas","volume":"23","author":"Garcia-Carbonero","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.cca.2026.121100_bb0310","series-title":"Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas\/Paragangliomas Associated With SDHB Mutations","author":"Bernardo-Casti\u00f1eira","year":"2026"},{"key":"10.1016\/j.cca.2026.121100_bb0315","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4158\/EP-2017-0057","article-title":"Pheochromocytoma: a genetic and diagnostic update","volume":"24","author":"Mercado-Asis","year":"2018","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cca.2026.121100_bb0320","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/joim.12869","article-title":"Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma","volume":"285","author":"Muth","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2026.121100_bb0325","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/0008-5472.CAN-17-2463","article-title":"Germline mutations in the mitochondrial 2-oxoglutarate\/malate carrier SLC25A11 gene confer a predisposition to metastatic paragangliomas","volume":"78","author":"Buffet","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.cca.2026.121100_bb0330","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajhg.2019.02.017","article-title":"Recurrent germline DLST mutations in individuals with multiple pheochromocytomas and paragangliomas","volume":"104","author":"Remacha","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2026.121100_bb0335","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","article-title":"Recurrent mutations of chromatin remodeling genes and kinase receptors in pheochromocytomas and paragangliomas","volume":"22","author":"Toledo","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.121100_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-026-09543-9","article-title":"Epigenetic and metabolic rewiring in metastatic pheochromocytomas and paragangliomas driven by SDHB mutations","author":"Cubiella","year":"2026","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cca.2026.121100_bb0345","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12022-024-09830-3","article-title":"The molecular classification of pheochromocytomas and paragangliomas: discovering the genomic and immune landscape of metastatic disease","volume":"35","author":"de Bresser","year":"2024","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0350","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cca.2026.121100_bb0355","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41467-023-36769-6","article-title":"Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma","volume":"14","author":"Calsina","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2026.121100_bb0360","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00432-017-2397-3","article-title":"SDHB-related pheochromocytoma and paraganglioma penetrance and genotype\u2013phenotype correlations","volume":"143","author":"Jochmanova","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cca.2026.121100_bb0365","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.121100_bb0370","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1158\/1078-0432.CCR-16-2250","article-title":"Targeted exome sequencing of krebs cycle genes reveals candidate cancer\u2013predisposing mutations in pheochromocytomas and paragangliomas","volume":"23","author":"Remacha","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.121100_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.574662","article-title":"Genetic and clinical profiles of pheochromocytoma and paraganglioma: a single center study","volume":"11","author":"Ma","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cca.2026.121100_bb0380","series-title":"Genetics in Endocrinology: The Genetics of Phaeochromocytoma: Using Clinical Features to Guide Genetic Testing","author":"Jafri","year":"2026"},{"key":"10.1016\/j.cca.2026.121100_bb0385","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"Amar","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cca.2026.121100_bb0390","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2026.121100_bb0395","series-title":"A Comprehensive Next Generation Sequencing\u2013Based Genetic Testing Strategy To Improve Diagnosis of Inherited Pheochromocytoma and Paraganglioma","author":"Rattenberry","year":"2026"},{"key":"10.1016\/j.cca.2026.121100_bb0400","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/jmedgenet-2018-105714","article-title":"Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma","volume":"56","author":"Aim","year":"2019","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cca.2026.121100_bb0405","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1210\/clinem\/dgad028","article-title":"Evidence for a founder effect of SDHB Exon 1 deletion in Brazilian patients with paraganglioma","volume":"108","author":"Fagundes","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0410","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgac014","article-title":"Universal germline panel testing for individuals with pheochromocytoma and paraganglioma produces high diagnostic yield","volume":"107","author":"Horton","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0415","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3892\/etm.2024.12784","article-title":"Clinical exome next-generation sequencing panel for hereditary pheochromocytoma and paraganglioma diagnosis","volume":"29","author":"Melli","year":"2024","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.cca.2026.121100_bb0420","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13148-023-01598-3","article-title":"A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide","volume":"15","author":"Chatzikyriakou","year":"2023","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.cca.2026.121100_bb0425","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.eprac.2020.09.011","article-title":"Chromogranin A in a cohort of pheochromocytomas and paragangliomas: usefulness at diagnosis and as an early biomarker of recurrence","volume":"27","author":"Parisien-La Salle","year":"2021","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cca.2026.121100_bb0430","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/iju.15423","article-title":"Chromogranin A as a diagnostic marker of pheochromocytoma and paraganglioma: A systematic review and meta-analysis","volume":"31","author":"Xing","year":"2024","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.cca.2026.121100_bb0435","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cca.2022.07.018","article-title":"Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma","volume":"534","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2026.121100_bb0440","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12014-023-09428-7","article-title":"Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization","volume":"20","author":"Vit","year":"2023","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.cca.2026.121100_bb0445","doi-asserted-by":"crossref","first-page":"RP107108","DOI":"10.7554\/eLife.107108.3","article-title":"Transcriptional subtypes on immune microenvironment and predicting postoperative recurrence and metastasis in human pheochromocytoma and paraganglioma","volume":"14","author":"Liu","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.cca.2026.121100_bb0450","first-page":"dgaf575","article-title":"PBK as a potential biomarker and therapeutic target for metastatic pheochromocytomas and paragangliomas","author":"Zhou","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0455","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouz\u00e9","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cca.2026.121100_bb0460","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3390\/cancers13071522","article-title":"MicroRNAs, long non-coding RNAs, and circular RNAs: potential biomarkers and therapeutic targets in pheochromocytoma\/paraganglioma","volume":"13","author":"Turai","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.121100_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jss.2019.04.086","article-title":"MicroRNA-210 may be a preoperative biomarker of malignant pheochromocytomas and paragangliomas","volume":"243","author":"Ruff","year":"2019","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.cca.2026.121100_bb0470","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1210\/clinem\/dgae797","article-title":"Biomarkers improving genetic and metastatic disease prediction in paraganglioma: insights from a prospective study","volume":"110","author":"Drossart","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2021.151801","article-title":"LncRNA expression and SDHB mutations in pheochromocytomas and paragangliomas","volume":"55","author":"Li","year":"2021","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2023.112106","article-title":"Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors","volume":"581","author":"M\u00f6ller","year":"2024","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cca.2026.121100_bb0485","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12022-020-09618-1","article-title":"The diagnostic dilemma of GATA3 immunohistochemistry in pheochromocytoma and paraganglioma","volume":"31","author":"Kimura","year":"2020","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0490","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12022-022-09730-4","article-title":"PHOX2B is a sensitive and specific marker for the histopathological diagnosis of pheochromocytoma and paraganglioma","volume":"33","author":"Miyauchi","year":"2022","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0495","doi-asserted-by":"crossref","first-page":"24141","DOI":"10.18632\/oncotarget.8234","article-title":"Phenylethanolamine N-methyltransferase downregulation is associated with malignant pheochromocytoma\/paraganglioma","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2026.121100_bb0500","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12022-018-9544-5","article-title":"Catecholamine-synthesizing enzymes in pheochromocytoma and extraadrenal paraganglioma","volume":"29","author":"Konosu-Fukaya","year":"2018","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0505","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12022-021-09694-x","article-title":"Immunohistochemical expression of choline acetyltransferase and catecholamine-synthesizing enzymes in head-and-neck and thoracoabdominal paragangliomas and pheochromocytomas","volume":"32","author":"Kimura","year":"2021","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0510","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12022-020-09633-2","article-title":"Immunohistochemical staining for SOX10 and SDHB in SDH-deficient paragangliomas indicates that sustentacular cells are not neoplastic","volume":"31","author":"Powers","year":"2020","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0515","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-021-09675-0","article-title":"Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0520","doi-asserted-by":"crossref","first-page":"2478312","DOI":"10.1080\/07853890.2025.2478312","article-title":"Prognostic significance of Ki-67 in assessing the risk of progression, relapse or metastasis in pheochromocytomas and paragangliomas","volume":"57","author":"Luo","year":"2025","journal-title":"Ann. Med."},{"key":"10.1016\/j.cca.2026.121100_bb0525","doi-asserted-by":"crossref","first-page":"e4661","DOI":"10.1210\/clinem\/dgaa608","article-title":"Predicting metastatic potential in pheochromocytoma and paraganglioma: a comparison of PASS and GAPP scoring systems","volume":"105","author":"Wachtel","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.121100_bb0530","doi-asserted-by":"crossref","first-page":"11588","DOI":"10.1038\/s41598-023-38606-8","article-title":"Cytoplasmic HIF-2\u03b1 as tissue biomarker to identify metastatic sympathetic paraganglioma","volume":"13","author":"Karakaya","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.121100_bb0535","first-page":"769","article-title":"The systems of metastatic potential prediction in pheochromocytoma and paraganglioma","volume":"10","author":"Wang","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.cca.2026.121100_bb0540","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/PAS.0000000000002238","article-title":"Validation and evaluation of 5 scoring systems for predicting metastatic risk in pheochromocytoma and paraganglioma","volume":"48","author":"Li","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.cca.2026.121100_bb0545","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00428-019-02553-5","article-title":"COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas\/paragangliomas","volume":"474","author":"Pierre","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.cca.2026.121100_bb0550","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/biomedicines10081813","article-title":"Clinical and pathological tools for predicting recurrence and\/or metastasis in patients with pheochromocytoma and paraganglioma","volume":"10","author":"Bima","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.cca.2026.121100_bb0555","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/joim.13791","article-title":"Preoperative prediction of metastatic pheochromocytoma and paraganglioma using clinical, genetic, and biochemical markers: A cohort study","volume":"296","author":"Park","year":"2024","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2026.121100_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187398","article-title":"Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma","volume":"12","author":"Koh","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2026.121100_bb0565","doi-asserted-by":"crossref","first-page":"103181","DOI":"10.1016\/j.eclinm.2025.103181","article-title":"Utility of disease probability scores to guide decision-making during screening for phaeochromocytoma and paraganglioma: a machine learning modelling cross sectional study","volume":"82","author":"Pamporaki","year":"2025","journal-title":"eClinicalMedicine"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:20:41Z","timestamp":1786422041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":112,"alternative-id":["S0009898126002822"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121100","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in laboratory diagnostic studies of pheochromocytoma and paraganglioma","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121100"}}